Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective randomized study of rivaroxaban in compensated cirrhosis
ChiCTR2100049083Phase 4Recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of rivaroxaban in Cirrhosis (2 arms), sponsored by Beijing YouAn Hospital. Primary endpoint: Improvement in liver stiffness by magnetic resonance elastography. Started Dec 2020; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Cirrhosis
Beyond the preview
Go deeper on ChiCTR2100049083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049083.